Treatment effects seen from 4 through 24 months of age, with fewer injuries at centers implementing TIPP
MONDAY, April 1, 2024 (HealthDay News) — Implementation of The Injury Prevention Program (TIPP), designed by the American Academy of Pediatrics, results in a reduction in parent-reported injuries at well-child checks (WCCs), according to a study published online April 1 in Pediatrics.
Eliana M. Perrin, M.D., M.P.H., from the Johns Hopkins University Schools of Medicine and Nursing in Baltimore, and colleagues conducted a stratified, cluster randomized trial at four academic medical centers. Two centers implemented TIPP screening and counselling materials at WCCs for ages 2 to 24 months and two centers implemented obesity prevention. Parents reported the number of child injuries since the previous WCC at each WCC. A total of 781 parent-infant dyads were enrolled: 349 in the TIPP group and 432 in the control group; 51 and 28 percent were Hispanic and non-Hispanic Black, respectively, and 87 percent were insured by Medicaid.
The researchers found that throughout follow-up, the adjusted odds of reporting injuries were significantly reduced at TIPP sites versus non-TIPP sites, with adjusted odds ratios of 0.77, 0.60, 0.32, 0.26, and 0.27 at four, six, 12, 18, and 24 months, respectively.
“Although further research is needed to determine if TIPP prevents serious injuries and prevents injuries in nontraining settings, our study provides important evidence that a primary care-based intervention can be effective in reducing injury,” the authors write.
Past Blast Exposure Tied to Long-Term Chronic Medical Diagnoses in Veterans
Mortality in Injured Children Linked to Higher SBP Thresholds Than Those That Define Hypotension
Extreme Heat Linked to 33 Clinically Reportable Diagnoses
ADHD Poses Additional Concussion Challenges for Athletes
Time-Restricted Eating Shows Possible Benefits for Patients With Huntington Disease
People With ADHD Experience 50 Percent More GI Symptoms
1 in 4 Former NFL Players Had CTE at Death in 2016 to 2021
Many With Atypical Alzheimer Disease Do Not Qualify for Anti-Amyloid Therapy